search
Back to results

Pain Control With Pre-operative Cryoneurolysis Following TKA

Primary Purpose

Osteo Arthritis Knee

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Cryoneurolysis (Iovera)
Sponsored by
Fondren Orthopedic Group L.L.P.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteo Arthritis Knee focused on measuring knee, joint replacement, total knee, cryoneurolysis, Iovera, TKA, pain

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • any patient scheduled for primary total knee arthroplasty(TKA)

Exclusion Criteria:

  • Bilateral TKA (patients routinely receive spinal anesthesia)
  • Minors
  • Patients reporting a history of Raynaud's disease
  • Patients with an open and/or infected wound on surgical knee
  • Patients who are taking opioids during the pre-operative period due to knee pain
  • Patients who cannot return for the cryoneurolysis treatment 7 days prior to surgery or post-operative clinical visits
  • Patients whose insurance would deny payment for the cryoneurolysis treatment
  • Pregnant patients
  • Patients unable to speak and read English

Sites / Locations

  • Fondren Orthopedic Group, L.L.P.Recruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Experimental

Control

Arm Description

Patients receiving Cryoneurolysis (Iovera) prior to total knee arthroplasty

Outcomes

Primary Outcome Measures

Veterans Rand-12 (VR-12)
VR-12 is a 12 item questionnaire that measures health related quality of life. Scores range from 0 to 100 with 50 being an average score and higher scores representing better health related quality of life.
Knee Injury and Osteoarthritis Outcomes Survey (KOOS Jr)
KOOS Jr. is a short questionnaire that evaluates knee pain and function. Scores range from 0 to 100 where 0 represents total knee disability and 100 represents perfect knee health.

Secondary Outcome Measures

Number of subject with an adverse effect from treatment
Any complication during treatment will be recorded.
Range of motion
During clinical office visits, your ability to bend and straighten your knee will be recorded.
Knee function
During clinical office visits, your ability to perform daily activities with regards to your knee will be recorded.
Knee swelling
The amount of swelling in your knee will be recorded.

Full Information

First Posted
January 9, 2019
Last Updated
June 17, 2019
Sponsor
Fondren Orthopedic Group L.L.P.
search

1. Study Identification

Unique Protocol Identification Number
NCT03818022
Brief Title
Pain Control With Pre-operative Cryoneurolysis Following TKA
Official Title
Effectiveness of Preoperative Cryoneurolysis (Iovera) for Postoperative Pain Control in Total Knee Arthroplasty
Study Type
Interventional

2. Study Status

Record Verification Date
June 2019
Overall Recruitment Status
Unknown status
Study Start Date
February 1, 2019 (Actual)
Primary Completion Date
December 2020 (Anticipated)
Study Completion Date
December 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondren Orthopedic Group L.L.P.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to assess the potential benefit of preoperative cryoneurolysis in postoperative pain management of total knee arthroplasty patients over current pain management protocol.
Detailed Description
Cryoneurolysis, is a novel technique that can yield temporary blockade of superficial sensory nerves, generating immediate and meaningful relief of pain.The technique generates an axonotmesis of the targeted peripheral nerves by percutaneously applying low temperatures (-100 °C to -20 °C). Wallerian degeneration is produced whereby the axons and the myelin sheath are damaged but the endoneurium, perineurium and epineurium remain intact. Therefore, permanent damage to the nerve is avoided as it retains its regenerative properties. With regards to the knee, the infrapatellar branch of the saphenous nerve (IPBSN), a sensory branch serving both the inferior and anterior portion of the knee capsule and the antero-medial skin of the knee is the prime target for the procedure. Your participation in this study requires that you allow the radiology department of Texas Orthopedic Hospital to administer Cryoneurolysis using the Iovera device with the functional smart tip approximately 1 week prior to total knee arthroplasty surgery. A highly localized cold zone is created via the Joule-Thompson effect as nitrous oxide enters the needles. Nothing is injected into the body and the nitrous oxide gas is vented safely out of the handpiece. Cryoneurolysis is administered following local anesthesia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteo Arthritis Knee
Keywords
knee, joint replacement, total knee, cryoneurolysis, Iovera, TKA, pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental
Arm Type
Experimental
Arm Description
Patients receiving Cryoneurolysis (Iovera) prior to total knee arthroplasty
Arm Title
Control
Arm Type
No Intervention
Intervention Type
Procedure
Intervention Name(s)
Cryoneurolysis (Iovera)
Intervention Description
Cryoneurolysis performed by radiology department 1 week prior to total knee arthroplasty
Primary Outcome Measure Information:
Title
Veterans Rand-12 (VR-12)
Description
VR-12 is a 12 item questionnaire that measures health related quality of life. Scores range from 0 to 100 with 50 being an average score and higher scores representing better health related quality of life.
Time Frame
up to 3 months
Title
Knee Injury and Osteoarthritis Outcomes Survey (KOOS Jr)
Description
KOOS Jr. is a short questionnaire that evaluates knee pain and function. Scores range from 0 to 100 where 0 represents total knee disability and 100 represents perfect knee health.
Time Frame
up to 3 months
Secondary Outcome Measure Information:
Title
Number of subject with an adverse effect from treatment
Description
Any complication during treatment will be recorded.
Time Frame
up to 3 months
Title
Range of motion
Description
During clinical office visits, your ability to bend and straighten your knee will be recorded.
Time Frame
up to 3 months
Title
Knee function
Description
During clinical office visits, your ability to perform daily activities with regards to your knee will be recorded.
Time Frame
up to 3 months
Title
Knee swelling
Description
The amount of swelling in your knee will be recorded.
Time Frame
up to 3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: any patient scheduled for primary total knee arthroplasty(TKA) Exclusion Criteria: Bilateral TKA (patients routinely receive spinal anesthesia) Minors Patients reporting a history of Raynaud's disease Patients with an open and/or infected wound on surgical knee Patients who are taking opioids during the pre-operative period due to knee pain Patients who cannot return for the cryoneurolysis treatment 7 days prior to surgery or post-operative clinical visits Patients whose insurance would deny payment for the cryoneurolysis treatment Pregnant patients Patients unable to speak and read English
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mitzi S Laughlin, PHD
Phone
713-799-2300
Email
Mitzi.Laughlin@fondren.com
Facility Information:
Facility Name
Fondren Orthopedic Group, L.L.P.
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Individual Site Status
Recruiting

12. IPD Sharing Statement

Learn more about this trial

Pain Control With Pre-operative Cryoneurolysis Following TKA

We'll reach out to this number within 24 hrs